As a fundamental solution to medical DX that cannot be achieved by simply introducing electronic medical records, AIBTRUST Co., Ltd. (Headquarters: Kita-ku, Osaka City) will launch the 'Medical AI / DX Consulting Business' for medical institutions in June 2026.

Background: The 'Invisible Risks' of Medical DX are Expanding

While the adoption of electronic medical records and generative AI is progressing, the following issues are becoming apparent in medical settings:

・Unprepared data: Abbreviations and documentation rules vary by doctor, preventing AI from functioning correctly.

・Legal risks: Issues to be sorted out before tool implementation, such as the Personal Information Protection Law, MIC guidelines, and third-party provision consent, are becoming more complex.

・System response: The 2026 medical fee revision will introduce a new 'Electronic Medical Information Collaboration System Development Surcharge (formerly Medical DX Promotion System Development Surcharge)', with stricter calculation requirements such as My Number Insurance Card usage rates and electronic prescription compatibility.

Many cases fail when trying to respond only by introducing tools. Based on the belief that 'the essence of medical DX lies in the development of a data infrastructure,' AIBTRUST is launching this consulting business.

Service Overview: One-Stop Support in Five Areas

01. DX Diagnosis and Current State Survey

Inventory hospital data, operational workflows, and existing systems to visualize bottlenecks and priorities.

02. Data/Manual Preparation

Support standardization of terms, abbreviations, and documentation rules, code mapping such as FHIR, and AI conversion of hospital manuals.

03. Legal and Security Arrangements

Comprehensively organize the Personal Information Protection Law, MIC guidelines, dynamic consent design, BAA contracts, and implementation policies for tools like AWS Bedrock.

04. Tool Selection and Implementation Support

Propose and implement the optimal tool configuration based on the hospital's operational and legal requirements.

05. Operational Support and Effect Measurement

Provide continuous support through phased deployment, KPI design, and adoption assistance.

How to Proceed: Start with a Free Consultation

STEP 01 Free Consultation (Online, 60 minutes)

STEP 02 Current State Survey and Issue Identification

STEP 03 Proposal and Quotation

STEP 04 Phased Implementation Support

Reasons to Choose AIBTRUST

・Expertise in medical settings through collaboration with Osaka University Hospital

・Design compliant with the Personal Information Protection Law and MIC guidelines

・End-to-end support system spanning AI, data, legal, and infrastructure

Launch Date and Application

Launching in June 2026

Apply for a free consultation here: https://www.aibtrust.jp/dx-consulting

Company Overview

Company Name: AIBTRUST Co., Ltd.

Representative: Representative Director Koichi Morioka

Headquarters: Kita-ku, Osaka City

Established: December 2023

Business: Medical AI/DX Consulting Business, Medical DX Solutions Business, Next-Generation Medical Registry Platform Business

URL: https://www.aibtrust.jp

Contact for Inquiries

AIBTRUST Co., Ltd.

Inquiry Form: https://www.aibtrust.jp/companycontact

FACT BOX

  • Source: PR TIMES
  • Category: New Product